Giraudo Bryan
SEC CIK 1740847 · EDGAR
BoughtSold
Most active insiders at PTGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DINESH V PH D | Pres, CEO, Dir | — | $60.58M |
| 2 | Ali Asif | CFO | — | $7.32M |
| 3 | Giraudo Bryan | Dir | — | $5.92M |
| 4 | Waddill William D. | Dir | — | $5.58M |
| 5 | MOLINA ARTURO MD | Chief Medical Off | — | $4.49M |
| 6 | SELICK HAROLD E | Dir | — | $2.52M |
| 7 | Williams Lewis T | Dir | — | $1.48M |
| 8 | O'Dowd Sarah A | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-11 20:25 | 2026-05-07 | PTGX | Protagonist Therapeutics, Inc | Giraudo Bryan | Dir | M - OptEx | $6.63 | +36.0K | 43.8K | +460% | +$238.6K |
| DM | 2026-05-11 20:25 | 2026-05-07+ | PTGX | Protagonist Therapeutics, Inc | Giraudo Bryan | Dir | S - Sale+OE | $100.12 | -41.1K | 12.7K | -76% | -$4.12M |
| DMI | 2026-05-11 20:25 | 2026-05-07+ | PTGX | Protagonist Therapeutics, Inc | Giraudo Bryan | Dir | S - Sale+OE | $100.05 | -18.0K | 0 | -100% | -$1.80M |
| D | 2026-01-06 | 2026-01-02 | PTGX | Protagonist Therapeutics, Inc | Giraudo Bryan | Dir | A - Grant | $0.00 | +2,695 | 17.8K | +18% | $0 |
| D | 2026-01-05 | 2026-01-02 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | A - Grant | $0.00 | +115.8K | 389.7K | +42% | $0 |
| 2025-10-02 | 2025-10-01 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | A - Grant | $0.00 | +181.2K | 274.0K | +195% | $0 | |
| D | 2025-01-06 | 2025-01-02 | PTGX | Protagonist Therapeutics, Inc | Giraudo Bryan | Dir | A - Grant | $0.00 | +5,130 | 15.1K | +51% | $0 |
| I | 2024-06-20 | 2024-06-18 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | P - Purchase | $0.59 | +100.0K | 480.0K | +26% | +$59.0K |
| 2024-03-28 | 2024-03-27 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | S - Sale | $1.16 | -6,430 | 92.7K | -6% | -$7,459 | |
| I | 2023-11-14 | 2023-11-13 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | P - Purchase | $0.56 | +200.0K | 380.0K | +111% | +$112.0K |
| DI | 2023-07-26 | 2023-07-24 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | A - Grant | $1.82 | +54.0K | 180.0K | +43% | +$98.3K |
| I | 2023-04-05 | 2023-04-04 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | P - Purchase | $1.02 | +55.0K | 126.0K | +77% | +$56.1K |
| DI | 2023-03-22 | 2023-03-20 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | P - Purchase | $0.97 | +50.0K | 71.0K | +238% | +$48.5K |
| I | 2022-07-15 | 2022-07-15 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | P - Purchase | $7.21 | +13.9K | 21.0K | +195% | +$100.0K |
| 2022-03-24 | 2022-03-23 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | COO, CFO | S - Sale | $8.92 | -10.7K | 99.2K | -10% | -$95.6K |
Purchase Sale Sale after option exercise All abbreviations